{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:16:49Z","timestamp":1794658609861,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2304900, 2022YFC2304905"],"award-info":[{"award-number":["2022YFC2304900, 2022YFC2304905"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12171387"],"award-info":[{"award-number":["12171387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68561-7","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:33:14Z","timestamp":1769020394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact and cost-effectiveness of doxycycline post-exposure prophylaxis in Australian men who have sex with men"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0277-9364","authenticated-orcid":false,"given":"Hao","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-7403","authenticated-orcid":false,"given":"Jason J.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-350X","authenticated-orcid":false,"given":"Michael W.","family":"Traeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0237-1473","authenticated-orcid":false,"given":"Benjamin P.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Stoov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-800X","authenticated-orcid":false,"given":"Mingwang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-084X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"68561_CR1","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","volume":"17","author":"M Unemo","year":"2017","unstructured":"Unemo, M. et al. Sexually transmitted infections: challenges ahead. Lancet Inf. ect. Dis. 17, e235\u2013e279 (2017).","journal-title":"Lancet Inf. ect. Dis."},{"key":"68561_CR2","unstructured":"HIV, viral hepatitis and sexually transmissible infections in australia: Annual surveillance report kirby institute. https:\/\/www.kirby.unsw.edu.au\/research\/reports\/asr2023 (2023)."},{"key":"68561_CR3","unstructured":"Regional action plans for ending AIDS and the epidemics of viral hepatitis and sexually transmitted infections 2022\u20132030. https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289058957."},{"key":"68561_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","volume":"18","author":"J-M Molina","year":"2018","unstructured":"Molina, J.-M. et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect. Dis. 18, 308\u2013317 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"68561_CR5","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","volume":"388","author":"AF Luetkemeyer","year":"2023","unstructured":"Luetkemeyer, A. F. et al. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N. Engl. J. Med. 388, 1296\u20131306 (2023).","journal-title":"N. Engl. J. Med."},{"key":"68561_CR6","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1056\/NEJMoa2304007","volume":"389","author":"J Stewart","year":"2023","unstructured":"Stewart, J. et al. Doxycycline prophylaxis to prevent sexually transmitted infections in women. N. Engl. J. Med. 389, 2331\u20132340 (2023).","journal-title":"N. Engl. J. Med."},{"key":"68561_CR7","doi-asserted-by":"publisher","first-page":"100760","DOI":"10.1016\/j.lanepe.2023.100760","volume":"34","author":"C B\u00e9b\u00e9ar","year":"2023","unstructured":"B\u00e9b\u00e9ar, C., Pereyre, S., Ber\u00e7ot, B. & Cazanave, C. Managing bacterial sexually transmitted infections (STIs) and preventing HIV\/STIs in Europe. Lancet Reg. Health Eur. 34, 100760 (2023).","journal-title":"Lancet Reg. Health Eur."},{"key":"68561_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","volume":"73","author":"LH Bachmann","year":"2024","unstructured":"Bachmann, L. H. et al. CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recomm. Rep. 73, 1\u20138 (2024).","journal-title":"MMWR Recomm. Rep."},{"key":"68561_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5694\/mja2.52258","volume":"220","author":"VJ Cornelisse","year":"2024","unstructured":"Cornelisse, V. J., Riley, B. & Medland, N. A. Australian consensus statement on doxycycline post-exposure prophylaxis (<scp>doxy-PEP<\/scp>) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men. Med. J. Aust. 220, 381\u2013386 (2024).","journal-title":"Med. J. Aust."},{"key":"68561_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/OLQ.0000000000002082","volume":"52","author":"MN Boschiero","year":"2025","unstructured":"Boschiero, M. N., Sansone, N. M. S., Matos, L. R. & Marson, F. A. L. Efficacy of doxycycline as preexposure and\/or postexposure prophylaxis to prevent sexually transmitted diseases: a systematic review and meta-analysis. Sex. Transm. Dis. 52, 65\u201372 (2025).","journal-title":"Sex. Transm. Dis."},{"key":"68561_CR11","volume":"33","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. Impact of screening and doxycycline prevention on the syphilis epidemic among men who have sex with men in British Columbia: a mathematical modelling study. Lancet Reg. Health Am. 33, 100725 (2024).","journal-title":"Lancet Reg. Health Am."},{"key":"68561_CR12","doi-asserted-by":"publisher","first-page":"100926","DOI":"10.1016\/S2666-5247(24)00168-X","volume":"5","author":"E Reichert","year":"2024","unstructured":"Reichert, E. & Grad, Y. H. Effects of doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections on gonorrhoea prevalence and antimicrobial resistance among men who have sex with men in the USA: a modelling study. Lancet Microbe 5, 100926 (2024).","journal-title":"Lancet Microbe"},{"key":"68561_CR13","doi-asserted-by":"publisher","unstructured":"Traeger, M. W. et al. Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections. Clin. Infect. Dis. ciad488 https:\/\/doi.org\/10.1093\/cid\/ciad488 (2023).","DOI":"10.1093\/cid\/ciad488"},{"key":"68561_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jama.2021.23487","volume":"327","author":"S Tuddenham","year":"2022","unstructured":"Tuddenham, S., Hamill, M. M. & Ghanem, K. G. Diagnosis and treatment of sexually transmitted infections. JAMA 327, 161 (2022).","journal-title":"JAMA"},{"key":"68561_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/sextrans-2024-056291","volume":"101","author":"A Ogunbajo","year":"2025","unstructured":"Ogunbajo, A. et al. Predictors of receiving a doxycycline postexposure prophylaxis (Doxy-PEP) prescription for the prevention of bacterial sexually transmitted infections (STIs) in a community-based clinic: a case\u2013control study. Sex. Transm. Infect. 101, 68\u201369 (2025).","journal-title":"Sex. Transm. Infect."},{"key":"68561_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","volume":"24","author":"J-M Molina","year":"2024","unstructured":"Molina, J.-M. et al. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2\u2008\u00d7\u20082 factorial design. Lancet Infect. Dis. 24, 1093\u20131104 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"68561_CR17","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1016\/S1473-3099(23)00356-0","volume":"23","author":"E Williams","year":"2023","unstructured":"Williams, E., Williamson, D. A. & Hocking, J. S. Frequent screening for asymptomatic chlamydia and gonorrhoea infections in men who have sex with men: time to re-evaluate?. Lancet Infect. Dis. 23, e558\u2013e566 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"68561_CR18","doi-asserted-by":"publisher","unstructured":"Dombrowski, J. C. et al. Evidence-informed provision of doxycycline postexposure prophylaxis for prevention of bacterial sexually transmitted infections. Clin. Infect. Dis. ciae527 https:\/\/doi.org\/10.1093\/cid\/ciae527 (2024).","DOI":"10.1093\/cid\/ciae527"},{"key":"68561_CR19","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1016\/S1473-3099(23)00359-6","volume":"23","author":"DM Whiley","year":"2023","unstructured":"Whiley, D. M. et al. Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis. Lancet Infect. Dis. 23, e268\u2013e269 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"68561_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/cid\/ciae309","volume":"80","author":"L Xiu","year":"2025","unstructured":"Xiu, L. & Peng, J. Challenges and considerations in implementing doxycycline post-exposure prophylaxis for sexually transmitted infection prevention in China. Clin. Infect. Dis. 80, 690\u2013691 (2025).","journal-title":"Clin. Infect. Dis."},{"key":"68561_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/cid\/ciaf089","volume":"80","author":"OO Soge","year":"2025","unstructured":"Soge, O. O. et al. Potential impact of doxycycline post-exposure prophylaxis on tetracycline resistance in Neisseria gonorrhoeae and colonization with tetracycline-resistant Staphylococcus aureus and Group A Streptococcus. Clin. Infect. Dis. 80, 1188\u20131196 (2025).","journal-title":"Clin. Infect. Dis."},{"key":"68561_CR22","doi-asserted-by":"publisher","first-page":"2100917","DOI":"10.2807\/1560-7917.ES.2022.27.18.2100917","volume":"27","author":"NA Medland","year":"2022","unstructured":"Medland, N. A. et al. Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: a global, systematic review, 1 January 2012 to 27 September 2020. Eurosurveillance 27, 2100917 (2022).","journal-title":"Eurosurveillance"},{"key":"68561_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/aje\/kwad175","volume":"193","author":"R Yaesoubi","year":"2024","unstructured":"Yaesoubi, R. et al. The impact of rapid drug susceptibility tests on gonorrhea burden and the life span of antibiotic treatments: a modeling study among men who have sex with men in the United States. Am. J. Epidemiol. 193, 17\u201325 (2024).","journal-title":"Am. J. Epidemiol."},{"key":"68561_CR24","doi-asserted-by":"crossref","unstructured":"Williamson, D. A. et al. Trends and risk factors for antimicrobial-resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018. Antimicrob. Agents Chemother. 63, 10\u20131128 (2019).","DOI":"10.1128\/AAC.01221-19"},{"key":"68561_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jac\/dkae073","volume":"79","author":"R Pitt-Kendall","year":"2024","unstructured":"Pitt-Kendall, R. et al. Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016\u201320. J. Antimicrob. Chemother. 79, 1060\u20131068 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"68561_CR26","doi-asserted-by":"publisher","first-page":"e11028","DOI":"10.2196\/11028","volume":"7","author":"D Callander","year":"2018","unstructured":"Callander, D. et al. Monitoring the control of sexually transmissible infections and blood-borne viruses: protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS). JMIR Res. Protoc. 7, e11028 (2018).","journal-title":"JMIR Res. Protoc."},{"key":"68561_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4097\/kjae.2017.70.2.144","volume":"70","author":"SG Kwak","year":"2017","unstructured":"Kwak, S. G. & Kim, J. H. Central limit theorem: the cornerstone of modern statistics. Korean J. Anesthesiol. 70, 144 (2017).","journal-title":"Korean J. Anesthesiol."},{"key":"68561_CR28","doi-asserted-by":"publisher","unstructured":"Hui, B. et al. Reducing STI burden in MSM with Doxy-PEP: evidence from individual-based modelling in Australia. 2025.06.24.25330172 Preprint at https:\/\/doi.org\/10.1101\/2025.06.24.25330172 (2025).","DOI":"10.1101\/2025.06.24.25330172"},{"key":"68561_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/OLQ.0000000000002079","volume":"52","author":"M Holt","year":"2025","unstructured":"Holt, M. et al. Acceptability of Doxycycline prophylaxis, prior antibiotic use, and knowledge of antimicrobial resistance among australian gay and bisexual men and nonbinary people. Sex. Transm. Dis. 52, 73\u201380 (2025).","journal-title":"Sex. Transm. Dis."},{"key":"68561_CR30","doi-asserted-by":"publisher","first-page":"107186","DOI":"10.1016\/j.ijid.2024.107186","volume":"147","author":"I Szondy","year":"2024","unstructured":"Szondy, I. et al. Doxycycline prophylaxis for the prevention of sexually transmitted infections: a systematic review and meta-analysis of randomized controlled trials. Int. J. Infect. Dis. 147, 107186 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"68561_CR31","unstructured":"STI guidelines australia | australian STI guidelines website. https:\/\/sti.guidelines.org.au\/."},{"key":"68561_CR32","unstructured":"Australian Government\u2014Department of Health and Aged Care. MBS online. https:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/Downloads-240301."},{"key":"68561_CR33","unstructured":"Australian Government\u2014Department of Health and Aged Care. The Pharmaceutical Benefits Scheme. https:\/\/www.pbs.gov.au\/browse\/downloads."},{"key":"68561_CR34","doi-asserted-by":"publisher","first-page":"e810","DOI":"10.1093\/cid\/ciac427","volume":"76","author":"K Lee","year":"2023","unstructured":"Lee, K. et al. Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) lost due to syphilis acquired in the United States in 2018. Clin. Infect. Dis. 76, e810\u2013e819 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"68561_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/infdis\/jiad047","volume":"227","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. The estimated lifetime quality-adjusted life-years lost due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018. J. Infect. Dis. 227, 1007\u20131018 (2023).","journal-title":"J. Infect. Dis."},{"key":"68561_CR36","doi-asserted-by":"publisher","unstructured":"Lai, H. et al. Impact and cost-effectiveness of doxycycline post-exposure prophylaxis in Australian men who have sex with men - Code and data repository. https:\/\/doi.org\/10.5281\/zenodo.17907511 (2025).","DOI":"10.5281\/zenodo.17907511"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68561-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68561-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68561-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:07:26Z","timestamp":1771549646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68561-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68561"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68561-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.W.T. reports speaker\u2019s honoraria and consulting fees from Gilead Sciences. All the other authors declared no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1846"}}